• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
Read more
© NCI/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 14th July 2015

Guest post: The Economics of Elevated Hospital Mortality at Weekends

Rachel Meacock reports on the economics of elevated hospital mortality at weekends. On 11th June Professor Matt Sutton of The University of Manchester presented an OHE lunchtime seminar on the economics of elevated hospital mortality at weekends. Professor Sutton’s presentation…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email

Rachel Meacock reports on the economics of elevated hospital mortality at weekends.

On 11th June Professor Matt Sutton of The University of Manchester presented an OHE lunchtime seminar on the economics of elevated hospital mortality at weekends. Professor Sutton’s presentation drew upon recent work published by Meacock, Doran and Sutton (2015).

Rachel Meacock, also of The University of Manchester, summarises the seminar in this guest post:

The NHS recently set out plans to move towards providing comprehensive hospital services seven days a week, as a response to findings that patients are significantly more likely to die if admitted to hospital at the weekend compared to during the week (NHS Commissioning board, 2013; NHS England, 2014). Prof Sutton discussed the evidence being used to support this policy, and presented estimates of its potential costs and benefits.

Prof Sutton explained that the highly quoted figure of a 16% increase in the risk of dying if admitted at the weekend is a relative risk, with the absolute increase being just 0.3 percentage points. The absolute risk increase is the numerical difference between the probability of dying if admitted at the weekend compared to if admitted during the week; the relative risk is the ratio of the probability of dying if admitted at the weekend to the probability of dying if admitted during the week. The relative risk does not give any information on the overall risk. In this case, the relative risk increase of 16% sounds much greater than the absolute risk increase of 0.3 percentage points. 

Prof Sutton also highlighted the lack of causal evidence between staffing and service levels and mortality rates.
Sutton and colleagues have estimated the likely costs and benefits of implementing comprehensive seven day services. Their focus was on emergency admissions, as this is the area in which the majority of excess weekend deaths occur and has been the focus of much of the policy debate.
 
It was noted that such service extensions will have an opportunity cost; requiring either an increase in training and recruitment of doctors or, more likely, a redistribution of the current workforce away from weekday cover. The introduction of a 7-day NHS could therefore narrow the gap between weekday and weekend death rates by raising mortality during the week.
 
Applying the weekday death rate to the volume of emergency admissions at the weekend, Sutton and colleagues estimate that between 4,355 and 5,353 lives could be saved annually if the mortality rate observed for patients admitted at the weekend was reduced to that experienced during the week. They estimate this to translate into a potential health gain of 29,727 – 36,539 QALYs per year if all of these deaths could be averted. Using the NICE £20,000 per QALY threshold, the NHS should spend no more than £595m – £731m to achieve a health gain of this size.
 
Whilst the potential benefits of extending services appear large, they must be compared with the additional costs of doing so. Using estimates produced by the NHS Seven Days a Week Forum, the annual cost of implementing seven-day hospital services is estimated to be between £1.07bn and £1.43bn. This exceeds the maximum amount that the NHS should spend to eradicate the weekend effect by a factor of 1.5 to 2.4, or between £339m and £831m.
 
Prof Sutton concluded that the statistics on increased mortality for those admitted at the weekend are insufficient by themselves to justify an organisational change. There is as yet no clear evidence: that 7-day working will, in isolation, reduce the weekend death rate; that lower weekend mortality rates can be achieved without increasing weekday death rates; or that such reorganisation is cost-effective.
 
Access the full study here.
 
References
NHS Commissioning Board. 2013. Everybody Counts: Planning for Patients 2013/14. NHS Commissioning Board: London.
 
NHS England. 2014. The forward view into action: planning for 2015/16. NHS England: London.
 
Funding acknowledgement: This research was funded by The National Institute for Health Research Health Services and Delivery Research (NIHR HS&DR) programme (project number 12/128/48). The views and opinions expressed are those of the authors and do not necessarily reflect those of the HS&RD programme, NIHR, NHS or the Department of Health.
 
OHE would like to thank Rachel Meacock for contributing this guest post.
 
 
  • Health Technology Assessment…
  • Policy, Organisation and…
  • Presentations

Related News

  • News
  • March 2020

How do we Get and Pay for New Antibiotics? Proposed New Models for Value Assessment and Contracting for Payment.

Read more
  • News
  • March 2020

Price Transparency: Good or Bad? What Does Literature and Theory Tell Us?

Read more
  • News
  • January 2020

Funding Challenges in the Malaysian Health Care System

Read more
  • News
  • January 2020

OHE at HESG Winter 2020

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!